SuperworthOrthopediatrics profit margin KIDS
Gross, operating and net profit as a share of revenue over the last twelve months, from 2016.
- Net margin, 12 months
- −15.7%
- Operating margin, 12 months
- −11.9%
- Net margin on a year earlier
- +3.2 pts
- Peer median
- 6.0%
Over the twelve months to Jun 30, 2026, Orthopediatrics kept −15.7% of its revenue as net profit, with an operating margin of −11.9% and a gross margin of 73.7%.
Five years earlier its net margin was −36.6%.
The median for 10 medical instruments and supplies stocks of a similar size is 6.0%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −16.8% | −16.6% | 73.1% |
| FY2024 | −18.5% | −17.1% | 72.6% |
| FY2023 | −14.1% | −18.0% | 74.8% |
| FY2022 | 1.0% | −20.8% | 74.1% |
| FY2021 | −16.6% | −18.4% | 74.9% |
| FY2020 | −46.3% | −37.6% | 77.4% |
| FY2019 | −18.9% | −12.5% | 75.3% |
| FY2018 | −20.9% | −16.6% | 74.2% |
| FY2017 | −19.6% | −14.2% | 75.5% |
| FY2016 | −17.6% | −16.4% | n/a |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −15.7% | +3.2 pts | −11.9% | |
| Q1 FY26 | −16.3% | +2.8 pts | −15.0% | |
| Q4 FY25 | −16.8% | +1.7 pts | −16.6% | |
| Q3 FY25 | −20.1% | −5.1 pts | −19.8% | |
| Q2 FY25 | −18.9% | −4.6 pts | −18.7% | |
| Q1 FY25 | −19.1% | −5.6 pts | −17.1% | |
| Q4 FY24 | −18.5% | −4.4 pts | −17.1% | |
| Q3 FY24 | −15.0% | +0.6 pts | −15.3% | |
| Q2 FY24 | −14.3% | −15.1 pts | −16.0% | |
| Q1 FY24 | −13.6% | −16.3 pts | −17.2% | |
| Q4 FY23 | −14.1% | −15.1 pts | −18.0% | |
| Q3 FY23 | −15.6% | −23.5 pts | −19.0% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Orthopediatrics' size, closest first, today.
| Company | Profit margin |
|---|---|
| KIDSOrthopediatrics | −15.7% |
| MOVMovado | 6.0% |
| MDXGMimedx | 1.8% |
| TCMDTactile Systems Technology | 7.1% |
| EMBCEmbecta | 8.6% |
| IRMDIradimed | 26.7% |
| STAAStaar Surgical | 1.1% |
| BVSBioventus | 9.4% |
| CDRECadre | 5.3% |
| INFUInfuSystem | 6.0% |
| EYENational Vision | 2.5% |
| Peer median | 6.0% |
Where Orthopediatrics ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Orthopediatrics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.